510(k) K971494
K971494 is an FDA 510(k) premarket notification submitted by Zymetx, Inc. for the device "VIRAZYME INFLUENZA ID TEST FOR INFLUENZA TYPES A AND B VIRUSES". The FDA issued a decision of Substantially Equivalent on September 10, 1997. The device falls under product code GNX (Antigens, Cf (Including Cf Control), Influenza Virus A, B, C), a Class I device regulated under 21 CFR 866.3330. Zymetx, Inc. has at least 3 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- September 10, 1997
- Date Received
- April 24, 1997
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Antigens, Cf (Including Cf Control), Influenza Virus A, B, C
- Device Class
- Class I
- Regulation Number
- 866.3330
- Review Panel
- MI
- Submission Type